RxDoctor Payments DataLook up a doctor →

Lance Bergstrom, MD

Ophthalmology · Fargo, NDNPI 1578509733

Payments from drug & device makers

$1,568,617in general payments, 2019–2025

Across 921 payments — averaging $1703.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$957K
  • Alcon Research LLC$334K
  • Ocular Therapeutix, Inc.$214K
  • Bausch Health US, LLC$31K
  • Sun Pharmaceutical Industries Inc.$20K
  • Mallinckrodt Enterprises LLC$5K
  • plus $8K from 20 others
$4,848in research payments, 2019–2025

Across 3 payments — averaging $1616.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$5K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,568,617 in reported general payments places this provider in the 95th percentile of 41 ophthalmology providers in North Dakota.

See all ophthalmology providers in North Dakota

Medicare billing

Part B allowed, 2024
$1,195,144
Medicare patients
688
Services billed
11,249

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Fargo

See the full list for North Dakota

Where these figures come from

Is this you, or does something look wrong? →